These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16669748)

  • 1. Practical considerations of new drugs: new choices for old problems.
    Frank T
    Consult Pharm; 2006 Apr; 21(4):276-8, 281-83. PubMed ID: 16669748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A look back at the most influential drug approvals of 2005.
    Laustsen G; Gilbert M; Wimett L
    Nurse Pract; 2006 Feb; 31(2):26, 29-36, 41; quiz 42-3. PubMed ID: 16452899
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs 06, part I.
    Hussar DA
    Nursing; 2006 Feb; 36(2):54-61; quiz 62-3. PubMed ID: 16462265
    [No Abstract]   [Full Text] [Related]  

  • 4. New drugs: exenatide, pramlintide acetate, and micafungin sodium.
    Hussar DA
    J Am Pharm Assoc (2003); 2005; 45(4):524-7. PubMed ID: 16128511
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs 06, part II.
    Hussar DA
    Nursing; 2006 Aug; 36(8):56-62; quiz 63-4. PubMed ID: 16888514
    [No Abstract]   [Full Text] [Related]  

  • 6. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
    Leinung MC; Grasso P
    Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenges of interpreting residual effects of hypnotics.
    Roth T
    Sleep; 2011 Oct; 34(10):1285-6. PubMed ID: 21966057
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
    Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
    Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exenatide and pramlintide: new therapies for diabetes.
    Want LL; Ratner R
    Int J Clin Pract; 2006 Dec; 60(12):1522-3. PubMed ID: 17109659
    [No Abstract]   [Full Text] [Related]  

  • 10. Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus.
    Hoogwerf BJ
    Cleve Clin J Med; 2006 May; 73(5):477-84. PubMed ID: 16708716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs: tigecycline, ziconotide, and clofarabine.
    Hussar DA
    J Am Pharm Assoc (2003); 2005; 45(5):636-9. PubMed ID: 16295652
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes basics. Exenatide and pramlintide. New meds on the block.
    Griffin S; Borders J
    Diabetes Self Manag; 2006; 23(4):74-6, 79. PubMed ID: 16888865
    [No Abstract]   [Full Text] [Related]  

  • 13. Update in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatide.
    Odegard PS; Setter SM; Iltz JL
    Diabetes Educ; 2006; 32(5):693-712. PubMed ID: 16971704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility that certain hypnotics might cause cancer in skin.
    Kripke DF
    J Sleep Res; 2008 Sep; 17(3):245-50. PubMed ID: 18844818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exenatide: use in humans].
    Sierra-Ascencio ME; Ríos-Vaca A; Reza-Albarrán A
    Gac Med Mex; 2006; 142(6):483-91. PubMed ID: 17201111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline and the need for a new broad-spectrum antibiotic class.
    Wilcox MH
    Surg Infect (Larchmt); 2006 Feb; 7(1):69-80. PubMed ID: 16509787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's new in clinical pharmacology and therapeutics.
    Chawla PS; Kochar MS
    WMJ; 2006 May; 105(3):24-9. PubMed ID: 16749321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUCAST technical note on tigecycline.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
    Clin Microbiol Infect; 2006 Nov; 12(11):1147-9. PubMed ID: 17063597
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.
    Parkes DG; Mace KF; Trautmann ME
    Expert Opin Drug Discov; 2013 Feb; 8(2):219-44. PubMed ID: 23231438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.